Towards Cerebrolysin Efficacy in Patients with «Silent» Cerebral Infarctions

Authors

  • V.N. Mishchenko State Institution «Institute of Neurology, Psychiatry and Narcology of National Academy of Medical Sciences of Ukraine», Kharkiv

DOI:

https://doi.org/10.22141/2224-0713.3.73.2015.78235

Keywords:

cerebral infarction, motor functions, cognitive functions, Cerebrolysin

Abstract

The article considers the issue of the treatment for «silent» cerebral infarctions. The study on Cerebrolysin efficacy in patients with this disease is provided. It is demonstrated that Cerebrolysin leads to significant improvement in motor and cognitive functions, such as stability, gait, attention, short-term memory, as well as to the improvement of the regulatory functions.

References

Lloyd-Jones D., Adams R.J., Brown Т.М. et al. Heart disease and stroke statistics — 2010 update: a report from the American Heart Association // Circulation. — 2010. — 121. — e46-215.

Report of the Director General. Life in the 21st Century: A vision for all. — Geneva, Switzerland: World Health Organization, 1998.

Feigin V.L., Lawes C.M., Bennett D.A., Anderson C.S. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century // Lancet Neurol. — 2003. — 2. — 43-53.

Strong K., Mathers C., Bonita R. Preventing stroke: saving lives around the world // Lancet Neurol. — 2007. — 6. — 182-7.

Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges // Lancet Neurol. — 2010. — 9. — 689-701.

Vermeer S.E., Den Heijer T., Koudstaal P.J., Oudkerk M., Hofman A., Breteler M.M. Incidence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study // Stroke. — 2003. — 34. — 3926.

Vermeer S.E., Longstreth W.T. Jr, Koudstaal P.J. Silent brain infarcts: a systematic review// Lancet Neurol. — 2007. — 6. — 611-9.

Moran С., Phan T.G., Srikanth V.K. Cerebral small vessel disease: a review of clinical, radiological, and histopathological phenotypes // International Journal of Stroke. — 2012. — Vol. 7, Issue 1. — P. 36-46.

Norrving B. Lacunar infarcts: no black holes in the brain are benign // Pract. Neurol. — 2008. — № 8. — P. 222-28.

Fisher C.M. Capsular infarcts: the underlying vascular lesions // Arch. Neurol. — 1979. — 36. — 65-73.

Fisher C.M. The arterial lesions underlying lacunes // Acta Neuropathol. — 1968. — 12. — 1-15.

Fisher C.M. Lacunes: small, deep cerebral infarcts // Neuro-logy. — 1965. — 15. — 774-84.

Garcia-Eroles L., Targa C., Comes E., Parra O. Clinical predictors of lacunar syndrome not due to lacunar infarction // BMC Neurol. — 2010. — 10. — 31 (1–6).

Seifert T., Enzinger C., Storch M.K., Pichler G., Niederkorn K., Fazekas F. Acute small subcortical infarctions on diffusion weighted MRI: clinical presentation and aetiology // Neurol. Neurosurg. Psychiatry. — 2005. — 76. — 1520-4.

Donnan G.A., Norrving B. Lacunes and lacunar syndromes // Handb. Clin. Neurol. — 2009. — 93. — 559-75.

Левин O.C. Дисциркуляторная энцефалопатия: современные представления о механизмах развития и лечения // Журнал доказательной медицины для практических врачей. — 2010. — № 9. — С. 3-7.

Яхно Н.Н., Захаров В.В. Сосудистые когнитивные расстройства // Русский медицинский журнал. — 2005. — Т. 13, № 12. — С. 2-7.

Чуканова Е.И. Церебролизин в лечении пациентов с синдромом мягкого когнитивного снижения // Трудный пациент. — 2008. — № 2–3. — С. 3-6.

Tinetti M.E. // New Engl. J. Med. — 2003. — Vol. 348(1). — P. 42-49.

Published

2015-07-06

Issue

Section

Original Researches